US EditionChaurasia Lab deepens work in metabolic disease target
Summary by Making the Rounds
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Chaurasia Lab deepens work in metabolic disease target
The Chaurasia Lab, led by Bhagirath Chaurasia, MSc, PhD, assistant professor in the Division of Endocrinology & Metabolism, has continued to explore emerging targets to reduce obesity and treat metabolic conditions. Their recent publication, “Ceramide-induced FGF13 impairs systemic metabolic health,” appears in Cell Metabolism and contributes to the group’s history of groundbreaking research in the […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
